GAIA-102
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GAIA-102, covering 2022-01-26 to 2025-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors [Phase 1]